The abstract is read at the publisher; the summary is JClub's.
Overexpression of thiol methyltransferases TMT1A (METTL7A) or TMT1B (METTL7B) in HT1080 cells reduces sensitivity to geranylgeranyltransferase inhibitors and blunts drug-induced cell-cycle arrest.
- Why it matters: The substrate scope of TMT1A/TMT1B and how their methylation impacts prenyltransferase inhibitor activity are not fully defined, limiting prediction of drug response.
- What they did: Mass spectrometry showed both enzymes methylate several thiol-containing farnesyltransferase and geranylgeranyltransferase inhibitors, and HT1080 cells were tested after TMT1A/TMT1B overexpression or TMT1A inhibition with DCMB (LY-78335).
- The result: TMT-dependent methylation is linked to decreased cellular activity of susceptible prenyltransferase inhibitors, and DCMB reversed TMT1A-driven resistance while restoring cell-cycle arrest in TMT1A-expressing cells.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.